Researchers at the Nanoscience Initiative at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made a breakthrough in the fight against viral diseases. Their study, ...

The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.

To test this strategy, the team engineered protein immunogens that mimic key HIV envelope structures known to initiate bnAb ...

Researchers have developed EVE-Vax, an AI tool that forecasts viral mutations and designs test proteins to guide next-generation vaccines. The breakthrough could allow scientists to build vaccines ...

Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

Vaccinating against HIV has been a decades-long effort, stymied by the virus’s high mutation rate and mask of human glycans.

Researchers said an effective HIV vaccine would need to stimulate the immune system to produce neutralising antibodies.